How to File a Patent for General Engineering Innovation
Introduction Patents are the foundation of any engineering innovation since their purpose is to preserve the inherent consequence of inventive […]
Blockchain and Patent Law Research
Introduction Patents are the foundation of any engineering innovation since their purpose is to preserve the inherent consequence of inventive […]
Patent number 366820 has been granted to CENTER OF INNOVATIVE AND APPLIED BIOPROCESSING that is titled A PROCESS FOR THE PRODUCTION OF PREBIOTIC OLIGOSACCHARIDES AND NEARLY ZERO CALORIE FUNCTIONAL SUGAR FROM CANE MOLASSES, AND USES OF THE SAME. The present invention discloses a significant enhancement in the known efficacy of the cane industry waste or by-product, cane molasses, by producing high-value biomolecules of reduced calorie, prebiotic and other functional properties of health benefits. The cane industry waste or by-product, cane molasses, does not have any known properties of prebiotic oligosaccharides, and D-allulose (or D-psicose). This patent falls under the category of Biotechnology. Overall, this patent covers a process involving the agro-industrial by-products of the sugar cane industry raw molasses, acceptor molecules extracted from starch industry residue, and the catalytic proteins with dextransucrase and D-psicose 3-epimerase activities as the key ingredients to produce high value non-digestible oligosaccharides and functional monosaccharide sugar- D-psicose.
Patent number 382579 has been granted to CISCO TECHNOLOGY, INC which is titled CONNECTION DEVICE AUTHENTICATION”. The patent applicant responded to this objection by stating that if the present invention provides a technical solution to a technical problem and has a technical effect then the same cannot be considered to fall under the category of algorithm or computer program per se. This patent falls under the category of Communication. Overall, this patent covers a method and apparatus provided for a secure interconnect between data modules, including a security apparatus within a secured data connection device installed with a security chip. The connection device may be authenticated prior to enabling a stacking feature. Authentication of a connection device may be used to ensure the quality and performance of the connection device and the data modules.
patent number 381277 has been granted to the UNIVERSITY OF CANBERRA titled COMPOSITIONS FOR MODULATING CANCER STEM CELLS AND USES THEREFOR. The patent applicant responded to this objection by stating that the claimed compound does not pertain to mere forms/derivatives of known compounds. Therefore, the present invention does not fall under section 3(d) of the Patents Act. This patent falls under the category of Pharmaceuticals. Overall, this patent covers composition and methods for modulating cancer stem cells. More particularly, the present invention discloses the use of lysine demethylase (LSD) inhibitors and protein kinase C theta inhibitors (PKC-θ) for inhibiting the growth of LSD- and/or PKC-θ-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including non-metastatic and metastatic cancer and/or for preventing cancer recurrence.
Patent number 381290 has been granted to TATA CONSULTANCY SERVICES LIMITED which is titled SYSTEMS AND METHODS FOR QUALITY MONITORING. The primary independent claim of this patent states a method for monitoring quality of software tools, the method being executed by a processor, the method comprises receiving, by an issue tracking module, an input indicative of an issue with at least one software tool, wherein the issue is indicative of a problem faced by a user while utilizing a functionality provided by the at least one software tool and ascertaining, by an analysis module, whether the issue is a data related issue, wherein the ascertaining comprises analyzing the issue based on pre-configured rules retrieved from application support rules, and wherein the data related issue comprises one or more of invalid data, incorrect format of data, junk values in data, incorrect file attributes, incorrect permissions to access a file, and data duplication. The patent applicant responded to this objection by stating that if the present invention provides a technical solution to a technical problem and has a technical effect then the same cannot be considered to fall under the category of algorithm or computer program per se. This patent falls under the category of Communication. Overall, this patent covers systems and methods for quality monitoring of software tools and data repositories. The method comprises receiving an input indicative of an issue with at least one software tool, ascertaining whether the issue is a data related issue, determining if the issue is a change request, on ascertaining the issue to be a data related issue and resolving the issue based in part on the analyzing.
Patent number 381370 has been granted toTELEFONAKTIEBOLAGET L M ERICSSON (PUBL) which is titled METHODS NETWORK NODES AND USER EQUIPMENTS IN A WIRELESS NETWORK FOR COMMUNICATING AN EPDCCH. The primary independent claim of this patent states a method performed by a network node of a wireless communication network, for communicating an enhanced Physical Downlink Control Channel, ePDCCH, to a user equipment, UE. The patent applicant responded to this objection by stating that if the present invention provides a technical solution to a technical problem and has a technical effect then the same cannot be considered to fall under the category of algorithm or computer program per see. This patent falls under the category of Communication. Overall, this patent covers a method performed by a network node of a wireless communication network, for communicating an enhanced Physical Downlink Control Channel, ePDCCH, to a user equipment, UE.
Patent number 381262 has been granted to JINA PHARMACEUTICALS, INC. that is titled IMPROVED PHARMACEUTICAL COMPOSITION OF ENDOXIFEN & PREPARATION THEREOF. The patent applicant responded to this objection by stating that the claimed compound does not pertain to mere forms/derivatives of known compounds. This patent falls under the category of Pharmaceuticals. Overall, this patent covers a pharmaceutical composition comprising a core, wherein said core comprises endoxifen or pharmaceutically acceptable salt thereof, a sub-coat surrounding the core, an enteric coat surrounding the sub-coat and optionally a color coat surrounding the enteric coat.
Patent number 378988 has been granted to SABIC GLOBAL TECHNOLOGIES B.V. that is titled CATALYST COMPOSITION FOR THE POLYMERIZATION OF OLEFINS. The patent applicant responded to this objection by stating that the claimed invention does not pertain to mere forms/derivatives of known compounds. The applicant further submits that the present set of claims are novel and inventive over the features described under prior arts and that neither documents specifically described the process as used in the present invention. This patent falls under the category of Polymer Technology. Overall, this patent covers a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a tumour antigen or a fragment, variant or derivative thereof, one histone stem-loop and a poly(A) sequence or a polyadenylation signal.
Patent number 378938 has been granted to SIMMONS William H. that is titled 4 FLUORO THIO CONTAINING INHIBITORS OF APP2 COMPOSITIONS THEREOF AND METHOD OF USE. The patent applicant responded to this objection by stating that the claimed compound does not pertain to mere forms/derivatives of known compounds. This patent falls under the category of Chemical. Overall, this patent covers a fluoro-thiol-containing compound that is capable of specifically inhibiting the enzyme, membrane-bound aminopeptidase P2 5 (APP2), whose natural substrate is bradykinin. The compound is useful as a pharmaceutical agent because by inhibiting bradykinin degradation, the compound allows endogenous bradykinin to exert its beneficial effects in the body including dilating coronary arteries, providing protective effects in the heart during myocardial ischemia/reperfusion injury, stimulating formation of new blood vessels, improving organ 10 function in chronic heart and renal disease, and improving glucose tolerance and insulin sensitivity.
Patent number 378841 has been granted to DAICEL CORPORATION which is titled NUTRIENT COMPOSITION HAVING LIPID METABOLISM IMPROVING ACTION. The patent applicant responded to this objection by stating that the claims of the present invention relate to the nutrient composition comprising a cellulose acetate having a compositional distribution index (CDI) which is defined by a mathematical formula which is an essential technical feature of the claimed nutrient composition and not a mathematical formula per se as defined under section 3k of the Patents Act. This patent falls under the category of Food. Overall, this patent covers a nutritional composition comprising a cellulose acetate having a total degree of acetyl substitution of 0.4 to 1.1.